5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile

Star0

DB07935ExperimentalSmall molecule

5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile: Overview.

Formula / weight: C₁₆H₉FN₄O · 292.2673 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL473119PubChem25218427

Structure

InChIKeyJYAHFMKZJRVTDT-UHFFFAOYSA-NSMILESCC1=NNC2=C1C(OC1=CC(=CC(=C1)C#N)C#N)=C(F)C=C2

Targets

Q72547pol

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with 5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account